At the BR1DGE symposium at ESPE-ESE 2025, experts discussed the benefits of early detection of people with presymptomatic type 1 diabetes (T1D) and the practical insights from ongoing T1D screening programs.
This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.